FOUNTAIN VALLEY, CALIFORNIA--(Marketwire - September 26, 2007) - Sutura, Inc. (“Sutura”) (OTCBB: SUTU), an innovative developer of minimally invasive vascular suturing devices, announced today that the first patient to receive a SuperStitch EL to close a Patent Foramen Ovale (PFO) is showing no left-to-right shunt. Doctors at Republic Hospital in Tbilisi, Georgia performed a Tranesophageal Echo (TEE) on the patient and reported that the 19-year-old female patient is clinically doing well one month after the closure of the PFO using the SuperStitch EL.
